These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3066297)

  • 1. Clearance of artificial immune complexes consisting of circulating cathodic antigen and monoclonal antibodies in Schistosoma mansoni infected mice.
    Kestens L; Mangelschots K; Van Marck EA; Gigase PL; Deelder AM
    Ann Soc Belg Med Trop; 1988 Sep; 68(3):241-54. PubMed ID: 3066297
    [No Abstract]   [Full Text] [Related]  

  • 2. Schistosoma mansoni: impaired clearance of model immune complexes consisting of circulating anodic antigen and monoclonal IgG1 in infected mice.
    Kestens L; Mangelschots K; Van Marck EA; Gigase PL; Deelder AM
    Parasitol Res; 1988; 74(4):356-62. PubMed ID: 3133652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma mansoni: analysis of monoclonal antibodies reactive with gut-associated antigens.
    van Dam GJ; Kornelis D; Van Zeyl RJ; Rotmans JP; Deelder AM
    Parasitol Res; 1993; 79(1):55-62. PubMed ID: 7682328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni: the circulating cathodic antigen forms an abundant product of 41/42 kDa in the urine of infected patients.
    Abdeen HH; Attallah AF; El-Mohamady HI; Harrison RA; Mansour MM
    Exp Parasitol; 1998 Nov; 90(3):286-9. PubMed ID: 9806874
    [No Abstract]   [Full Text] [Related]  

  • 5. Schistosoma mansoni: in vitro and in vivo excretion of CAA and CCA by developing schistosomula and adult worms.
    van Dam GJ; Bogitsh BJ; van Zeyl RJ; Rotmans JP; Deelder AM
    J Parasitol; 1996 Aug; 82(4):557-64. PubMed ID: 8691363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of in vitro prepared heterologous antigen-antibody complexes in mice infected with Schistosoma mansoni.
    Kestens L; Van Marck EA; Gigase PL
    Contrib Microbiol Immunol; 1983; 7():63-72. PubMed ID: 6600672
    [No Abstract]   [Full Text] [Related]  

  • 7. Clearance kinetics of heterologous antigen and antigen-antibody complexes in Schistosoma mansoni infected mice.
    Kestens L; Gigase PL
    Ann Soc Belg Med Trop; 1984 Mar; 64(1):21-36. PubMed ID: 6732302
    [No Abstract]   [Full Text] [Related]  

  • 8. Schistosoma mansoni: microfluorometric determination of circulating anodic antigen and antigen-antibody complexes in infected hamster serum.
    Deelder AM; Van Dalen DP; Van Egmond JG
    Exp Parasitol; 1978 Apr; 44(2):216-24. PubMed ID: 658220
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunofluorescent localization of Schistosoma mansoni circulating cathodic antigen in tissues of infected mice using monoclonal antibody.
    Deelder AM; el-Dosoky I; Van Marck EA; Qian ZL
    Z Parasitenkd; 1985; 71(3):317-23. PubMed ID: 3892957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Schistosoma mansoni M antigen in circulating immune-complexes and in kidneys of infected hamsters.
    Carlier Y; Bout D; Capron A
    Trans R Soc Trop Med Hyg; 1980; 74(4):534-8. PubMed ID: 7445051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectron microscopical localization of a circulating antigen in the excretory system of Schistosoma mansoni. Ultrastructural localization studies of the excretory system of S. mansoni.
    Bogers JJ; Nibbeling HA; Van Marck EA; Deelder AM
    Parasitol Res; 1995; 81(5):375-81. PubMed ID: 7501635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
    Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
    Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental transfer of schistosomal antigens and antibodies.
    Romia SA; Handoussa AE; Youseff SA; el Zayat MM
    J Egypt Soc Parasitol; 1992 Dec; 22(3):575-82. PubMed ID: 1431274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni: description of a potentially useful monoclonal antibody that recognizes soluble egg antigen (SEA).
    Nakhle MC; Carneiro CR
    Rev Inst Med Trop Sao Paulo; 1997; 39(6):353-4. PubMed ID: 9674287
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of developmentally regulated epitopes of Schistosoma mansoni egg glycoprotein antigens.
    Weiss JB; Strand M
    J Immunol; 1985 Aug; 135(2):1421-9. PubMed ID: 2409151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenaemia and antigenuria in Schistosomiasis mansoni.
    Kamel MA; Kamal KA; Mansour M; el Adawi AI
    J Egypt Soc Parasitol; 1996 Dec; 26(3):789-95. PubMed ID: 8918051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni circulating anodic antigen but not circulating cathodic antigen interacts with complement component C1q.
    van Dam GJ; Seino J; Rotmans JP; Daha MR; Deelder AM
    Eur J Immunol; 1993 Nov; 23(11):2807-12. PubMed ID: 8223856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni eggs excrete specific free oligosaccharides that are detectable in the urine of the human host.
    Robijn ML; Koeleman CA; Hokke CH; Deelder AM
    Mol Biochem Parasitol; 2007 Feb; 151(2):162-72. PubMed ID: 17188764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thomsen-Friedenreich oncofetal antigen in Schistosoma mansoni : localization and immunogenicity in experimental mouse infection.
    Thors C; Jansson B; Helin H; Linder E
    Parasitology; 2006 Jan; 132(Pt 1):73-81. PubMed ID: 16393356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.